Literature DB >> 17594073

CRRT - still far from being a standardised BEST treatment?

Michael Joannidis, Lui G Forni.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17594073     DOI： 10.1007/s00134-007-0755-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  18 in total

1.  Daily hemodialysis and the outcome of acute renal failure.

Authors:  Helmut Schiffl; Susanne M Lang; Rainald Fischer
Journal:  N Engl J Med       Date:  2002-01-31       Impact factor: 91.245

2.  Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: a double-blind, randomized, crossover study.

Authors:  A C de Pont; H M Oudemans-van Straaten; K J Roozendaal; D F Zandstra
Journal:  Crit Care Med       Date:  2000-02       Impact factor: 7.598

3.  Practice patterns in the management of acute renal failure in the critically ill patient: an international survey.

Authors:  Zaccaria Ricci; Claudio Ronco; Giuseppe D'Amico; Riccardo De Felice; Stefano Rossi; Irene Bolgan; Monica Bonello; Nereo Zamperetti; Dimitris Petras; Gabriella Salvatori; Maurizio Dan; Pasquale Piccinni
Journal:  Nephrol Dial Transplant       Date:  2005-12-02       Impact factor: 5.992

4.  Effect of filtration volume of continuous venovenous hemofiltration in the treatment of patients with acute renal failure in intensive care units.

Authors:  Matthias Brause; A Neumann; T Schumacher; B Grabensee; Peter Heering
Journal:  Crit Care Med       Date:  2003-03       Impact factor: 7.598

5.  External validation of severity scoring systems for acute renal failure using a multinational database.

Authors:  Shigehiko Uchino; Rinaldo Bellomo; Hiroshi Morimatsu; Stanislao Morgera; Miet Schetz; Ian Tan; Catherine Bouman; Ettiene Macedo; Noel Gibney; Ashita Tolwani; Gordon S Doig; Heleen Oudemans van Straaten; Claudio Ronco; John A Kellum
Journal:  Crit Care Med       Date:  2005-09       Impact factor: 7.598

6.  Continuous veno-venous hemofiltration without anticoagulation in high-risk patients.

Authors:  H K Tan; I Baldwin; R Bellomo
Journal:  Intensive Care Med       Date:  2000-11       Impact factor: 17.440

7.  Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial.

Authors:  C Ronco; R Bellomo; P Homel; A Brendolan; M Dan; P Piccinni; G La Greca
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

8.  Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies.

Authors:  Stanislao Morgera; Anne K Kraft; Gerda Siebert; Friedrich C Luft; Hans-H Neumayer
Journal:  Am J Kidney Dis       Date:  2002-08       Impact factor: 8.860

9.  Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators.

Authors:  Shigehiko Uchino; Rinaldo Bellomo; Hiroshi Morimatsu; Stanislao Morgera; Miet Schetz; Ian Tan; Catherine Bouman; Ettiene Macedo; Noel Gibney; Ashita Tolwani; Heleen Oudemans-van Straaten; Claudio Ronco; John A Kellum
Journal:  Intensive Care Med       Date:  2007-06-27       Impact factor: 17.440

10.  Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study.

Authors:  Michael Joannidis; Jordan Kountchev; Markus Rauchenzauner; Nicola Schusterschitz; Hanno Ulmer; Andreas Mayr; Romuald Bellmann
Journal:  Intensive Care Med       Date:  2007-06-12       Impact factor: 17.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.